Work

The clinical-stage TLR5 agonist, Entolimod, mediates antimetastatic activity by stimulating a CXCR3-dependent NK-DC-CD8+ T cell axis

Year: 2016

Type: conference-abstract

Source: The Journal of Immunology

DOI: 10.4049/jimmunol.196.supp.75.5

Authors: Craig M Brackett, Bojidar M Kojouharov, Sandra O Gollnick, Lyudmila G Burdelya, Scott I Abrams, Andrei V Gudkov

Institution: Roswell Park Comprehensive Cancer Center

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4313360294

Cites:

Cited by:

Related to: 10